Chalcones against the hallmarks of cancer: a mini-review.

Nat Prod Res

Laboratório de Produtos Bioativos, Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Published: September 2022

Chalcones (1,3-diphenylpropen-1-ones) are a class of flavonoids that have been shown a broad spectrum of biological activities with therapeutic potential. Naturally occurring chalcones or synthetic chalcone derivatives have been extensively investigated as anticancer compounds. Cancer is still among the leading causes of death globally, although cancer treatments have improved over the past decades. Most of chemotherapeutic drugs target proliferating tumor cells; however, the cancer cells capabilities are also associated to tumor surround microenvironment. Thereby, the search of new compounds with a broad antitumor activity is still a great challenge. The cytotoxicity mechanisms of chalcones are beyond apoptosis induction in tumor cells, which make them promising compound for cancer therapy. In this mini-review we summarized recent studies that describe the anticancer potential of chalcones related to some of hallmarks of cancer. We shed a light on sustaining proliferative signaling, tumor-promoting inflammation, activating invasion and metastasis, inducing angiogenesis and resisting cell death.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14786419.2021.2000980DOI Listing

Publication Analysis

Top Keywords

chalcones hallmarks
8
hallmarks cancer
8
tumor cells
8
cancer
6
chalcones
5
cancer mini-review
4
mini-review chalcones
4
chalcones 13-diphenylpropen-1-ones
4
13-diphenylpropen-1-ones class
4
class flavonoids
4

Similar Publications

Article Synopsis
  • The CDAA-HFD mouse model is utilized to study metabolic dysfunction-associated steatohepatitis (MASH) by simulating disease progression and testing various treatments.
  • The study evaluated several drugs, including semaglutide and lanifibranor, for their effectiveness in reversing fibrosis and improving liver conditions after different time points on the CDAA-HFD diet.
  • Findings indicate that while semaglutide and lanifibranor showed partial benefits when used preventively, elafibranor was the only drug that improved fibrosis significantly, highlighting the importance of timing in pharmacological interventions.
View Article and Find Full Text PDF
Article Synopsis
  • Metabolic dysfunction-associated steatotic liver disease (MASLD) features liver fat accumulation, cell injury, and inflammation, which are explored in this study using a liver-on-a-chip model to simulate disease mechanisms.* -
  • The model incorporates mouse liver cells and immune cells to test the effects of acetaminophen and free fatty acids, mimicking acute liver injury and MASLD, respectively.* -
  • Results show that while lanifibranor combats inflammation, resmetirom reduces fat buildup in liver cells, highlighting the biochip's utility for testing liver disease treatments.*
View Article and Find Full Text PDF

Aβ plaque formation is one of the preliminary pathologic events that occur post traumatic brain injury (TBI) which is also among the most noteworthy hallmarks of AD. Their pre symptomatic detection is therefore vital for better disease management. Chalcone-picolinic acid chelator derivative, 6-({[(6-carboxypyridin-2-yl)methyl](2-{4-[(2E)-3-[4-(dimethyl amino)phenyl]prop-2-enoyl]phenoxy}ethyl)amino}methyl)pyridine-2-carboxylic acid, Py-chal was synthesized to selectively identify amyloid plaques formed post head trauma using SPECT imaging by stable complexation to Tc with > 97% efficiency without compromising amyloid specificity.

View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer is the most common malignancy among women and is largely curable in early stages, but treatment failure due to drug resistance is a significant issue.
  • Chalcones, which are chemical compounds that can lead to flavonoids, show potential against various aspects of breast cancer, including growth and metastasis, making them promising candidates for new treatments.
  • The review focuses on chalcone hybrids developed since 2018, discussing their effectiveness, mechanisms, and potential for overcoming current challenges in breast cancer therapy.
View Article and Find Full Text PDF

Alzheimer's disease (AD) is a formidable neurodegenerative disorder characterized by cognitive decline, memory impairment and inability to perform everyday tasks. In the pursuit of innovative diagnostic and therapeutic strategies, the synthesis and application of radiolabelled compounds have garnered significant attention. This review delves into the synthesis and biological significance of radiolabelled 1,3-diaryl-2-propen-1-ones, commonly known as chalcones, as Aβ imaging probes for AD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!